Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
Patents for C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom (40,304)
11/2007
11/13/2007CA2213080C 1-aryl-2-acylamino-ethane compounds and their use as neurokinin especially neurokinin 1 antagonists
11/13/2007CA2157856C Fluoroalkyl/alkenyl-substituted benzoylguanidines, process for their preparation, their use as a medicament or diagnostic, and medicament containing them
11/08/2007WO2007127726A2 Inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
11/08/2007WO2007127704A1 Cyclohexyl substituted pyrrolidinones as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
11/08/2007WO2007127693A1 Substituted pyrrolidinones as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
11/08/2007WO2007127688A2 Inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
11/08/2007WO2007125952A1 Amine derivative having npy y5 receptor antagonist activity
11/08/2007WO2007125845A1 Sulfonimide-type monomer, and polymer thereof
11/08/2007WO2007103584A3 Polyamides for treating human papilloma virus
11/08/2007US20070259941 Ramipril formulation
11/08/2007US20070259925 Dpp iv inhibitors
11/08/2007US20070259863 Arylphenylamino-,Arylphenylamide-, and Arylphenylether-Sulfide Derivatives
11/08/2007DE10318326B4 Verfahren zur Herstellung von Aziridinen und N-Vinylamiden A process for the production of aziridines and N-vinylamides
11/08/2007CA2650683A1 Amine derivative having npy y5 receptor antagonist activity
11/08/2007CA2650383A1 Diazeniumdiolated non-steroidal anti-inflammatory drugs, compositions thereof, and related methods
11/08/2007CA2650035A1 Poly (ethylene glycol) containing chemically disparate endgroups
11/08/2007CA2649650A1 Substituted pyrrolidinones as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
11/08/2007CA2649111A1 Cyclohexyl substituted pyrrolidinones as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
11/08/2007CA2648236A1 Inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
11/08/2007CA2646624A1 Inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
11/07/2007EP1852419A1 Method for producing fluorinated proline derivative
11/07/2007EP1851213A2 Mitotic kinesin inhibitors
11/07/2007EP1851210A2 Nitro-substituted phenyl-piperazine compounds, their preparation and use in medicaments
11/07/2007EP1851198A1 Substituted pyrroles, compositions containing same, method for making same and use thereof
11/07/2007CN101068780A Methods for the preparation of stereoisomerically enriched amines
11/07/2007CN101068772A N-(3-amino-2-hydroxy-propyl) substituted alkylamide compounds
11/07/2007CN101068551A 喹啉速激肽受体拮抗剂 Quinoline tachykinin receptor antagonists
11/07/2007CN101066945A Process of synthesizing 3-substituted lactan compound
11/07/2007CN100347170C Azabicyclo-octane and nonane derivatives with DPP-IV inhibiting activity
11/07/2007CN100347151C Novel aminobenzoephenones
11/07/2007CN100346779C Liquid pharmaceutical composition
11/06/2007US7291746 Preparing levetiracetam by deaminomethylation of the pure enantiomer intermediate: N-(dialkylamino- (or -pyrrolidinyl-, piperidinyl-, morpholinyl-, piperazinyl- or alkylpiperazinyl-)methyl)2-pyrrolidonylbutyramide or its acid addition salt
11/06/2007US7291713 For modifying polypeptides
11/06/2007US7291643 E.g., N-[4-(5-cyano-1-methyl-1H-pyrrol-2-yl)phenyl]propane-1-sulfonamide and tert-butyl 2-cyano-5-{4-{(ethylsulfonyl)amino]phenyl}-1H-pyrrole-1-carboxylate; useful for contraception and hormone replacement therapy
11/06/2007US7291621 Treating rheumatoid arthritis, psoriasis, reperfusion injury, cardiovascular , autoimmune, inflammatory disorders and bronchial asthma; e.g., 2-Methoxynaphthalene-1-carboxylic acid benzyl-indan-2-yl-amide
11/06/2007US7291620 N-alkyl phenylcarboxamide beta-secretase inhibitors for the treatment of Alzheimer's disease
11/06/2007US7291618 (3,3-Difluoropyrrolidin-1-yl)-((2S,4S)-4-(4-(pyrimidin-2-yl) piperazin-1-yl)pyrrolidin-2-yl)methanone, usedin treating diabetic complications including diabetic neuropathy, diabetic nephropathy, diabetic microangiopathy, and the like.
11/06/2007US7291617 Arylamidine derivative or salt thereof
11/06/2007CA2263927C Heterocyclic thioesters and ketones
11/06/2007CA2223112C 1,2-bis-adducts of stable nitroxides with substituted ethylenes and stabilized compositions
11/01/2007WO2007124337A1 Biphenyl amide lactam derivatives as inhibitors of 11- beta-hydroxysteroid dehydrogenase 1
11/01/2007WO2007122745A1 N-tert-butoxycarbonyl-2-pyrrolidinones and process for producing the same
11/01/2007WO2007122199A1 Synthesis and uses of pyroglutamic acid derivatives
11/01/2007WO2007121868A1 Alkoxyalkyl-substituted cyclic ketoenols
11/01/2007WO2007103501A3 Method and apparatus for conducting microwave assisted organic reactions with gas-phase reactants
11/01/2007WO2007057768A3 Sulfonyl derivatives
11/01/2007WO2007047146A3 Inhibitors of viral replication
11/01/2007US20070255056 Method for manufacture of compounds related to the class of substituted sulfonyl urea anti-diabetics
11/01/2007US20070254945 Aminocyclohexyl ether compounds and uses thereof
11/01/2007US20070254943 pulmonary disorders; bronchodilators; 2-[(S)-1-{2-[4-(2-Ethylaminoethyl)phenyl]ethyl}pyrrolidin-3-yl]-2,2-diphenylacetamide
11/01/2007US20070254875 Androgen Receptor Modulator Compounds and Methods
11/01/2007US20070252140 Heterocyclic Radical or Diradical, the Dimers, Oligomers, Polymers, Dispiro Compounds and Polycycles Thereof, the Use Thereof, Organic Semiconductive Material and Electronic or Optoelectronic Component
11/01/2007CA2649762A1 Synthesis and uses of pyroglutamic acid derivatives
11/01/2007CA2649552A1 Alkoxyalkyl-substituted cyclic ketoenols
10/2007
10/31/2007EP1849792A1 Biphosphine ruthenium complexes with chiral diamine ligands as catalysts
10/31/2007EP1849781A1 Substituted 3-Amino-4-hydroxy pyrrolidines compounds, their preparation and use as medicaments
10/31/2007EP1849469A1 Arylsulfonamide derivatives for use as ccr3 antagonists in the treatment of inflammatory and immunological disorders
10/31/2007EP1848692A1 AZOLYLACYLGUANIDINES AS ß-SECRETASE INHIBITORS
10/31/2007EP1848691A1 Process for the preparation of indolone derivative
10/31/2007EP1534678B1 Pleuromutilin derivatives as antimicrobbials
10/31/2007EP1246795B1 Antibacterial agents
10/31/2007EP0910564B1 D-amino acid derived inhibitors of cysteine and serine proteases
10/31/2007CN101065355A N- [ (3s)- pyrrolidin-3-yl]- benzamide derivatives as monoamine re-uptake inhibitors
10/31/2007CN101062928A Process for preparing 2-pyrrolidinyl-1h-pyrrolo[3,2-d]pyrimidine inhibitors of nucleoside metabolism
10/31/2007CN101062913A Preparation method of hydroxyproline-zinc chelate complex
10/31/2007CN100345834C 异羟肟酸衍生物 Hydroxamic acid derivatives
10/31/2007CN100345827C Bicyclic aromatic compound
10/30/2007US7288676 Arylphenyl-substituted cyclic ketoenols
10/30/2007US7288571 Thyroid receptor ligands and method II
10/30/2007US7288566 Inhibit 20-hydroxyeicosatetraenoic acid (20-HETE)-producing enzymes; kidney disease
10/30/2007US7288565 Azasugar compound
10/30/2007CA2421548C Amidine inhibitors of serine proteases
10/30/2007CA2264002C Naphthyl compounds, intermediates, compositions, and methods of use
10/25/2007WO2007120647A2 Compositions useful as inhibitors of voltage-gated sodium channels
10/25/2007WO2007118899A1 Heterocyclic arylsulphones suitable for treating disorders that respond to modulation of the serotonin 5ht6 receptor
10/25/2007WO2007118873A2 Polymorphs of atorvastatin sodium and magnesium salts
10/25/2007WO2007099552A3 Novel crystalline form of atovastatin hemi-magnesium
10/25/2007WO2007096903A3 New crystalline form of atorvastatin hemi-calcium
10/25/2007WO2007076158A8 Processes for preparing darifenacin hydrobromide
10/25/2007US20070249847 Method for Producing Acetamidopyrrolidine Derivatives and Intermediate Compounds Thereof
10/25/2007US20070249845 Process for preparing a crystalline form of atorvastatin hemi-calcium
10/25/2007US20070249832 For agriculture crops
10/25/2007US20070249705 N-(1-(2,3-Dihydro-1H-Inden-5Yl)-2-Oxo-3-Pyrrolidinyl)-Sulfonamide Derivatives for Use as Factor Xa Inhibitors
10/25/2007US20070249701 Cyclic amine CCR5 receptor antagonists
10/25/2007US20070249670 Glycogen Phosphorylase Inhibitor Compounds and Pharmaceutical Compositions Thereof
10/25/2007US20070249591 Biaryl Amino Acids and Their Use in Dna Binding Oligomers
10/25/2007US20070249578 New amidino derivatives and their use as thrombin inhibitors
10/25/2007US20070248594 Cxcr1 and cxcr2 chemokine antagonists
10/25/2007US20070245810 Detection Cartridges, Modules, Systems and Methods
10/25/2007DE102006018828A1 Alkoxyalkyl-substituierte cyclische Ketoenole Alkoxyalkyl-substituted cyclic ketoenols
10/25/2007DE102006018345A1 Aufhell- und/oder Färbemittel mit Amidinen Reducing and / or coloring with amidines
10/25/2007CA2648891A1 Heterocyclic arylsulphones suitable for treating disorders that respond to modulation of the serotonin 5ht6 receptor
10/25/2007CA2648202A1 Compositions useful as inhibitors of voltage-gated sodium channels
10/24/2007EP1847536A1 Synthesis and uses of pyroglutamic acid derivatives
10/24/2007EP1847263A2 Inhibitors against the production and release of inflammatory cytokines
10/24/2007EP1846372A2 Compounds for inflammation and immune-related uses
10/24/2007EP1846363A2 Adamantyl derivatives as inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme
10/24/2007EP1534671A4 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds
10/24/2007CN101061120A [3.2.0] heterocyclic compounds and methods of using the same
10/24/2007CN101061097A Novel gamma secretase inhibitors
1 ... 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 ... 404